For the year ending 2025-12-31, MFA had -$214,644K decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income/(loss) | 176,783 |
| Net (gain)/loss on residential whole loans | 138,840 |
| Impairment and other net (gain)/loss on securities and other portfolio investments, net | -61,543 |
| Net (gain)/loss on real estate owned | -6,887 |
| Accretion of purchase discounts and amortization of purchase premiums on residential whole loans and securities | -1,228 |
| Provision/(reversal of provision) for credit losses on residential whole loans and other assets | 936 |
| Net (gain)/loss on derivatives used for risk management purposes | -65,612 |
| Net (gain)/loss on securitized debt measured at fair value through earnings | -42,003 |
| Net margin received/(paid) for derivatives used for risk management purposes | 96,068 |
| Net other non-cash (gains)/losses included in net income | 67,399 |
| (increase)/decrease in other assets | -4,465 |
| Increase/(decrease) in other liabilities | 7,383 |
| Net cash provided by/(used in) operating activities | 76,245 |
| Purchases and origination of residential whole loans, loan related investments and capitalized advances | 2,688,693 |
| Proceeds from sales of residential whole loans | 274,921 |
| Principal payments on residential whole loans and loan related investments | 2,436,939 |
| Purchases of securities | 2,162,706 |
| Proceeds from sales of securities and other assets | 46,813 |
| Principal payments on securities | 289,649 |
| Proceeds from sales of real estate owned | 96,429 |
| Other investing activities | 78,853 |
| Net cash provided by/(used in) investing activities | -1,785,501 |
| Principal payments on financing agreements with mark-to-market collateral provisions | 2,695,221 |
| Proceeds from borrowings under financing agreements with mark-to-market collateral provisions | 4,343,097 |
| Principal payments on other collateralized financing agreements | 1,901,450 |
| Proceeds from borrowings under other collateralized financing agreements | 1,980,927 |
| Payments made for other collateralized financing agreement related costs | 10,892 |
| Redemption and repurchase of convertible senior notes | 0 |
| Proceeds from issuance of senior notes | 0 |
| Payments made for settlements and unwinds of swaps | 27,278 |
| Proceeds from issuance of preferred stock, net of expenses | 9,311 |
| Proceeds from issuances of common stock, net of expenses | -68 |
| Payments made for the repurchase of common stock | 15,313 |
| Dividends paid on preferred stock | 40,317 |
| Dividends paid on common stock and dividend equivalents | 148,184 |
| Net cash provided by/(used in) financing activities | 1,494,612 |
| Net increase/(decrease) in cash, cash equivalents and restricted cash | -214,644 |
| Cash, cash equivalents and restricted cash at beginning of period | 601,312 |
| Cash, cash equivalents and restricted cash at end of period | 386,668 |
MFA FINANCIAL, INC. (MFA)
MFA FINANCIAL, INC. (MFA)